Resources

Proteomics Databases



Metabolomics Databases

• • How to Choose a Proteomics Method for Serum, Plasma, or CSF Samples

  A method-selection guide for serum, plasma, and CSF samples comparing identification, DDA, and DIA routes with a decision tree and route comparison tables.

• • Serum, Plasma, or CSF Proteomics: Which Analysis Strategy Fits Your Study?

  An analysis-strategy guide for serum, plasma, and CSF proteomics, comparing identification, quantitative, differential, and pathway approaches for biofluid projects.

• • What Can Affect the Results of a Serum, Plasma, or CSF Proteomics Study?

  A results-expectation guide covering factors that affect serum, plasma, and CSF proteomics outcomes, including sample condition, design choices, deliverables, and interpretation limits.

• • How to Prepare Serum, Plasma, and CSF Samples for Proteomics Analysis?

  A sample-preparation matrix and checklist for serum, plasma, and CSF proteomics covering collection matching, plasma anticoagulant choice, and pre-shipment information.

• • Membrane Protein Interaction Analysis with IP-MS Validated Antibodies

  Learn how IP-MS validated antibodies support membrane protein Co-IP-MS when ordinary IP is difficult, and when to use extraction support or membrane interaction services.

• • Does IP Validation Mean an Antibody Is Suitable for IP-MS?

  Learn whether IP validation proves IP-MS suitability, when IP-capable antibodies are enough, and when to choose an IP-MS validated antibody for discovery workflows.

• • What Does “IP-MS Validated Antibody” Mean?

  Learn what IP-MS validated antibody means, what validation evidence should show, what the label does not guarantee, and how to evaluate reagents before purchase.

• • Common Causes of High Background in IP-MS Experiments

  Learn common causes of high IP-MS background and how matched controls, isotype antibodies, coupled beads, and IP-MS validated reagents reduce nonspecific binding.

• • IP-MS Antibodies vs Western Blot Antibodies: Why Application Validation Matters

  Learn why western blot validation and IP-MS validation test different antibody performance, and how to match application evidence to IP, Co-IP, IP-MS, AP-MS, or pull-down-MS workflows.

• • How EV Purity Affects LC-MS/MS Exosome Proteomics Results

  A problem-solving guide to how EV purity, background proteins, and buffer chemistry affect LC-MS/MS exosome proteomics reliability and quality control decisions.